Sinopharm's (1099.HK), a Chinese pharmaceutical company, Covid-19 vaccine achieved a 86% efficacy in trials conducted in the United Arab Emirates, according to UAE's Ministry of Health and Prevention. In addition, the company is also waiting for the approval of the China regulator to release the vaccine in China.
From a technical point of view, the stock broke above a declining channel. In addition, the bullish cross between 20-day and 50-day moving averages has been identified. Both technical events would suggest the bullish reversal signal. Hence, bullish readers should set the support level at HK$17.80, while the resistance levels would be located at HK$20.50 and HK$21.80.
Source: GAIN Capital, TradingView
From a technical point of view, the stock broke above a declining channel. In addition, the bullish cross between 20-day and 50-day moving averages has been identified. Both technical events would suggest the bullish reversal signal. Hence, bullish readers should set the support level at HK$17.80, while the resistance levels would be located at HK$20.50 and HK$21.80.
Source: GAIN Capital, TradingView
Latest market news
Yesterday 01:00 PM
Yesterday 08:00 AM
Yesterday 03:00 AM
January 11, 2025 10:00 PM
January 11, 2025 05:00 PM